|
C17ORF71 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63239999995124E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.021900E-03 |
| Normal-vs-Stage2 |
1.752280E-02 |
| Normal-vs-Stage3 |
4.495300E-03 |
| Normal-vs-Stage4 |
2.375800E-01 |
| Stage1-vs-Stage2 |
2.720200E-01 |
| Stage1-vs-Stage3 |
1.057440E-01 |
| Stage1-vs-Stage4 |
9.635800E-01 |
| Stage2-vs-Stage3 |
7.960800E-01 |
| Stage2-vs-Stage4 |
4.525600E-01 |
| Stage3-vs-Stage4 |
3.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66034999999898E-05 |
| Normal-vs-AfricanAmerican |
6.582700E-03 |
| Normal-vs-Asian |
3.054200E-01 |
| Caucasian-vs-AfricanAmerican |
5.851800E-01 |
| Caucasian-vs-Asian |
5.274000E-01 |
| AfricanAmerican-vs-Asian |
6.020200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.170000E-04 |
| Normal-vs-Female |
9.65619999959699E-07 |
| Male-vs-Female |
3.301000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.084400E-02 |
| Normal-vs-Extreme_Weight |
3.889600E-02 |
| Normal-vs-Obese |
1.076350E-03 |
| Normal-vs-Extreme_Obese |
3.191800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.689600E-01 |
| Normal_Weight-vs-Obese |
5.957200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.852800E-01 |
| Extreme_Weight-vs-Obese |
1.770150E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.156400E-01 |
| Obese-vs-Extreme_Obese |
7.593400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.660600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.95219999960572E-07 |
| Normal-vs-Age(61-80Yrs) |
6.437500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.617200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.757700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.659700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.735200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.408200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.250500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.795000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.045200E-04 |
| Normal-VS-Type2 PRCC |
1.141730E-03 |
| Normal-VS-KIRP CIMP |
4.312200E-02 |
| Normal-VS-Unclassified PRCC |
1.677160E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.510800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.478000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.455900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.247600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.770600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.403600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.306100E-02 |
| Normal-vs-N1 |
1.320230E-03 |
| Normal-vs-N2 |
7.982800E-01 |
| N0-vs-N1 |
2.520000E-02 |
| N0-vs-N2 |
6.915600E-01 |
| N1-vs-N2 |
2.055000E-01 |
|
|
